News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
95,188 Results
Type
Article (6972)
Company Profile (39)
Press Release (88177)
Multimedia
Podcasts (10)
Webinars (2)
Section
Business (27873)
Career Advice (128)
Deals (4011)
Drug Delivery (34)
Drug Development (14217)
Employer Resources (12)
FDA (2940)
Job Trends (2132)
News (49584)
Policy (6070)
Tag
Academia (430)
Accelerated approval (6)
Adcomms (7)
Allergies (35)
Alliances (9099)
ALS (17)
Alzheimer's disease (282)
Antibody-drug conjugate (ADC) (59)
Approvals (2915)
Artificial intelligence (66)
Autoimmune disease (12)
Automation (5)
Bankruptcy (19)
Best Places to Work (1806)
BIOSECURE Act (16)
Biosimilars (107)
Biotechnology (27)
Bladder cancer (28)
Brain cancer (6)
Breast cancer (70)
Cancer (614)
Cardiovascular disease (32)
Career advice (112)
Career pathing (3)
CAR-T (28)
CDC (9)
Cell therapy (104)
Cervical cancer (4)
Clinical research (11797)
Collaboration (261)
Compensation (61)
Complete response letters (11)
COVID-19 (563)
CRISPR (9)
C-suite (65)
Cystic fibrosis (14)
Data (632)
Denatured (2)
Depression (8)
Diabetes (47)
Diagnostics (583)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (35)
Drug pricing (39)
Drug shortages (1)
Duchenne muscular dystrophy (36)
Earnings (9729)
Editorial (9)
Employer branding (3)
Employer resources (10)
Events (12226)
Executive appointments (149)
FDA (3394)
Frontotemporal dementia (2)
Funding (181)
Gene editing (30)
Generative AI (8)
Gene therapy (110)
GLP-1 (120)
Government (1356)
Grass and pollen (1)
Guidances (39)
Healthcare (1986)
HIV (9)
Huntington's disease (6)
IgA nephropathy (5)
Immunology and inflammation (60)
Immuno-oncology (3)
Indications (11)
Infectious disease (611)
Inflammatory bowel disease (53)
Inflation Reduction Act (7)
Influenza (21)
Intellectual property (16)
Interviews (11)
IPO (1851)
IRA (15)
Job creations (391)
Job search strategy (108)
Kidney cancer (3)
Labor market (6)
Layoffs (61)
Leadership (1)
Legal (569)
Liver cancer (13)
Longevity (6)
Lung cancer (99)
Lymphoma (42)
Machine learning (3)
Management (2)
Manufacturing (152)
MASH (17)
Medical device (1208)
Medtech (1209)
Mergers & acquisitions (2289)
Metabolic disorders (114)
Multiple sclerosis (23)
NASH (2)
Neurodegenerative disease (24)
Neuropsychiatric disorders (1)
Neuroscience (390)
NextGen: Class of 2025 (705)
Non-profit (354)
Now hiring (12)
Obesity (44)
Opinion (52)
Ovarian cancer (29)
Pain (9)
Pancreatic cancer (21)
Parkinson's disease (19)
Partnered (3)
Patents (39)
Patient recruitment (27)
Peanut (22)
People (8121)
Pharmaceutical (11)
Pharmacy benefit managers (5)
Phase I (3875)
Phase II (4916)
Phase III (4314)
Pipeline (439)
Policy (85)
Postmarket research (298)
Preclinical (1521)
Press Release (66)
Prostate cancer (27)
Psychedelics (6)
Radiopharmaceuticals (40)
Rare diseases (106)
Real estate (925)
Recruiting (4)
Regulatory (4926)
Reports (11)
Research institute (392)
Resumes & cover letters (11)
Rett syndrome (1)
RNA editing (1)
RSV (15)
Schizophrenia (16)
Series A (40)
Series B (15)
Service/supplier (3)
Sickle cell disease (9)
Special edition (4)
Spinal muscular atrophy (22)
Sponsored (9)
Startups (586)
State (1)
Stomach cancer (4)
Supply chain (11)
Tariffs (15)
The Weekly (8)
Vaccines (227)
Venture capital (10)
Weight loss (18)
Women's health (3)
Date
Today (25)
Last 7 days (84)
Last 30 days (367)
Last 365 days (6024)
2025 (3348)
2024 (6549)
2023 (7001)
2022 (9175)
2021 (9549)
2020 (8250)
2019 (5899)
2018 (4586)
2017 (5102)
2016 (4663)
2015 (5320)
2014 (3748)
2013 (2911)
2012 (2999)
2011 (3155)
2010 (2581)
Location
Africa (93)
Alabama (14)
Alaska (1)
Arizona (13)
Arkansas (2)
Asia (7776)
Australia (891)
California (1465)
Canada (295)
China (236)
Colorado (36)
Connecticut (33)
Delaware (60)
Europe (14141)
Florida (189)
Georgia (25)
Idaho (13)
Illinois (70)
India (13)
Indiana (42)
Iowa (7)
Japan (50)
Kansas (4)
Kentucky (11)
Louisiana (2)
Maine (5)
Maryland (353)
Massachusetts (1034)
Michigan (28)
Minnesota (55)
Mississippi (2)
Missouri (18)
Montana (5)
Nebraska (1)
Nevada (5)
New Hampshire (3)
New Jersey (551)
New Mexico (4)
New York (414)
North Carolina (224)
North Dakota (9)
Northern California (629)
Ohio (45)
Oklahoma (7)
Oregon (3)
Pennsylvania (225)
Puerto Rico (1)
Rhode Island (6)
South America (136)
South Carolina (3)
Southern California (612)
Tennessee (4)
Texas (199)
United States (5173)
Utah (29)
Virginia (21)
Washington D.C. (7)
Washington State (112)
West Virginia (1)
Wisconsin (12)
95,188 Results for "samsung biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Samsung Biologics reports first quarter 2025 financial results
April 23, 2025
·
4 min read
Legal
J&J Takes Samsung Bioepis to Court Over ‘Unlawful’ Stelara Biosimilar Sublicense
Samsung Bioepis allegedly entered into an agreement with a third-party health company, allowing it to market its own private label of a Stelara biosimilar.
February 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development
January 8, 2025
·
3 min read
Press Releases
Samsung Bioepis’ European Whitepaper Proposes Solutions to Bridge Policy Gaps that Hinder Healthy Market Competition and Timely Access to Biosimilar Medicines
July 14, 2025
·
5 min read
Press Releases
Samsung Biologics reports fourth quarter and fiscal year 2024 financial results
January 22, 2025
·
4 min read
Business
Samsung Biologics Reports First Quarter 2024 Financial Results
Samsung Biologics, a global contract development and manufacturing organization, announced financial results for the first quarter of fiscal year 2024.
April 24, 2024
·
4 min read
Manufacturing
Samsung Biologics Continues Mega-Deal Streak With $1.4B European Contract
The deal follows a $1.06 billion U.S. contract in July 2024 and a $1.24 billion agreement with an Asia-based pharma a few months later.
January 23, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Samsung Bioepis Enters into a Strategic Partnership with NIPRO for Commercialization of Multiple Biosimilars in Japan
June 9, 2025
·
1 min read
Press Releases
Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference
January 15, 2025
·
4 min read
Press Releases
Samsung Biologics signs manufacturing deal with European pharmaceutical company
November 20, 2024
·
3 min read
1 of 9,519
Next
